Tower Research Capital LLC (Trc) Trevi Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,903 shares of TRVI stock, worth $15,846. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,903

Previous 7,061 44.72%

Holding current value

$15,846

Previous $21,000 38.1%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.58 - $3.51 $8,147 - $11,084	-3,158 Reduced 44.72%	3,903 $13,000
Q2 2024 Aug 13, 2024	BUY	$2.44 - $3.36 $15,740 - $21,675	6,451 Added 1057.54%	7,061 $21,000
Q1 2024 May 15, 2024	SELL	$1.3 - $3.7 $9,031 - $25,703	-6,947 Reduced 91.93%	610 $2,000
Q4 2023 Feb 13, 2024	BUY	$1.06 - $2.05 $1,170 - $2,263	1,104 Added 17.11%	7,557 $10,000
Q3 2023 Nov 14, 2023	BUY	$2.11 - $2.47 $10,446 - $12,228	4,951 Added 329.63%	6,453 $14,000
Q2 2023 Aug 14, 2023	BUY	$1.8 - $3.44 $2,703 - $5,166	1,502 New	1,502 $3,000
Q3 2022 Nov 10, 2022	BUY	$1.54 - $4.28 $9,104 - $25,303	5,912 Added 152.61%	9,786 $15,000
Q2 2022 Aug 15, 2022	SELL	$1.8 - $3.39 $10,085 - $18,994	-5,603 Reduced 59.12%	3,874 $11,000
Q1 2022 May 12, 2022	BUY	$0.46 - $2.48 $533 - $2,876	1,160 Added 13.95%	9,477 $21,000
Q4 2021 Feb 14, 2022	BUY	$0.68 - $1.5 $2,389 - $5,271	3,514 Added 73.16%	8,317 $7,000
Q3 2021 Nov 15, 2021	BUY	$1.29 - $2.18 $794 - $1,342	616 Added 14.71%	4,803 $7,000
Q2 2021 Aug 16, 2021	BUY	$2.0 - $2.76 $5,900 - $8,141	2,950 Added 238.48%	4,187 $10,000
Q1 2021 May 17, 2021	SELL	$2.36 - $3.55 $9,418 - $14,168	-3,991 Reduced 76.34%	1,237 $3,000
Q4 2020 Feb 16, 2021	BUY	$2.42 - $3.99 $9,246 - $15,245	3,821 Added 271.57%	5,228 $13,000
Q3 2020 Nov 16, 2020	BUY	$3.5 - $7.62 $4,924 - $10,721	1,407 New	1,407 $6,000
Q4 2019 Feb 07, 2020	SELL	$2.78 - $4.7 $6,516 - $11,016	-2,344 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$4.2 - $7.79 $4,796 - $8,896	1,142 Added 95.01%	2,344 $11,000
Q2 2019 Aug 13, 2019	BUY	$7.5 - $10.12 $9,015 - $12,164	1,202 New	1,202 $9,000

Others Institutions Holding TRVI

# of Institutions

Shares Held

57.1M

Call Options Held

136K

Put Options Held

5.4K

View Full List

About Trevi Therapeutics, Inc.

Ticker TRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,322,500
Market Cap $237M
Description
Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...

More about TRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Trevi Therapeutics, Inc. Transaction History